Evidence map›Paper›PMID 17311116›Full record

GuidelineThe Canadian journal of cardiology2007

CCS/CAR/CANM/CNCS/CanSCMR joint position statement on advanced noninvasive cardiac imaging using positron emission tomography, magnetic resonance imaging and multidetector computed tomographic angiography in the diagnosis and evaluation of ischemic heart disease--executive summary.

R S B Beanlands, B J W Chow, A Dick, M G Friedrich, K Y Gulenchyn, M Kiess, H Leong-Poi, R M Miller, G Nichol, M Freeman and 13 more

Registry-linked trialOpen access · greenAbstract readPractice Guideline
In one paragraph

Guideline in The Canadian journal of cardiology, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01412827 (Diagnostic and Prognostic Accuracy of Stress SPECT Myocardial Perfusion Imaging With Half the Usual Radiotracer Dose), which is not on this map. Cited by 34 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
34citing papers in PubMed, 2 pooled it
5.3field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01412827 nacompletednot on this mapstarted 2010, after this paper: background citation

Diagnostic and Prognostic Accuracy of Stress SPECT Myocardial Perfusion Imaging With Half the Usual Radiotracer Dose

TypeinterventionalSponsorOttawa Heart Institute Research CorporationRan2010 to 2014Enrolled18ConditionsCoronary Artery DiseaseArms1/2 dose of 99mTc OR 201Tl tracers
3 · Its place in the literature

Who cites it

34 citing papers in PubMed, 2 syntheses or guidelines pooled it, 101 citations in OpenAlex.

  1. Guideline
  2. Guideline
  3. Trial
  4. Trial
  5. Article
  6. Article
  7. Site qualification and clinical interpretation standards forJournal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology · 2021
    Article
  8. Article
  9. Article
  10. Role of Cardiac PET in Clinical Practice.Current treatment options in cardiovascular medicine · 2017
    Review
  11. ASNC imaging guidelines/SNMMI procedure standard for positron emission tomography (PET) nuclear cardiology procedures.Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology · 2016
    Article
  12. Review
  13. Novel plasma and imaging biomarkers in heart failure with preserved ejection fraction.International journal of cardiology. Heart & vasculature · 2015
    Review
  14. Review
  15. The role of PET quantification in cardiovascular imaging.Clinical and translational imaging · 2014
    Article
  16. Review
  17. Article
  18. Myocardial perfusion imaging with PET.Imaging in medicine · 2013
    Article
  19. Quantification of regional myocardial blood flow estimation with three-dimensional dynamic rubidium-82 PET and modified spillover correction model.Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology · 2012
    Article
  20. Automated quantitative Rb-82 3D PET/CT myocardial perfusion imaging: normal limits and correlation with invasive coronary angiography.Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology · 2012
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors at 1 institution in 1 country.

R S B BeanlandsUniversity of Ottawa Heart Institute, Ottawa, Canada. rbeanlands@ottawaheart.ca
B J W Chow
A Dick
M G Friedrich
K Y Gulenchyn
M Kiess
H Leong-Poi
R M Miller
G Nichol
M Freeman
P Bogaty
G Honos
G Hudon
G Wisenberg
J Van Berkom
K Williams
K Yoshinaga
J Graham
Canadian Cardiovascular Society
Canadian Association of Radiologists
Canadian Association of Nuclear Medicine
Canadian Nuclear Cardiology Society
Canadian Society of Cardiac Magnetic Resonance
Canadian Cardiovascular Society · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundOver the past few decades, advanced imaging modalities with excellent diagnostic capabilities have emerged. The aim of the present position statement was to systematically review existing literature to define Canadian recommendations for their clinical use.

methodsA systematic literature review to 2005 was conducted for positron emission tomography (PET), multidetector computed tomographic angiography and magnetic resonance imaging (MRI) in ischemic heart disease. Papers that met the criteria were reviewed for accuracy, prognosis data and study quality. Recommendations were presented to primary and secondary panels of experts, and consensus was achieved.

resultsIndications for PET include detection of coronary artery disease (CAD) with perfusion imaging, and defining viability using fluorodeoxyglucose to determine left ventricular function recovery and/or prognosis after revascularization (class I). Detection of CAD in patients, vessel segments and grafts using computed tomographic angiography was considered class IIa at the time of the literature review. Dobutamine MRI is class I for CAD detection and, along with late gadolinium enhancement MRI, class I for viability detection to predict left ventricular function recovery. Imaging must be performed at institutions and interpreted by physicians with adequate experience and training.

conclusionsCardiac imaging using advanced modalities (PET, multidetector computed tomographic angiography and MRI) is useful for CAD detection, viability definition and, in some cases, prognosis. These modalities complement the more widespread single photon emission computed tomography and echocardiography. Given the rapid evolution of technology, initial guidelines for clinical use will require regular updates. Evaluation of their integration in clinical practice should be ongoing; optimal use will require proper training. A joint effort among specialties is recommended to achieve these goals.

Indexed as

Coronary AngiographyMagnetic Resonance ImagingPositron-Emission TomographyTomography, X-Ray ComputedHumansMyocardial Ischemia

Identifiers

PMID17311116
PMCPMC2650646
OpenAlexW2033798293

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.